High prevalence of occult thrombosis in cases of mild/moderate COVID-19

Budong Chen1, Chunguo Jiang2, Bing Han3

  • 1The Radiology Department, Beijing Ditan Hospital, Capital Medical University, Beijing, China.

Abstract

Insights

Mild/moderate COVID-19 significantly increases the risk of venous thromboembolism (VTE), with 82.6% of patients developing thrombosis. Computed tomography venography (CTV) is crucial for detecting this thrombosis in COVID-19 patients.

Area of Science:

  • Medical research
  • Cardiovascular science
  • Infectious disease

Background:

  • Thrombosis is frequently observed in severe COVID-19 cases.
  • Limited data exists on thromboembolism incidence in mild/moderate COVID-19.
  • Normal coagulation tests do not exclude thrombotic risk in these patients.

Purpose of the Study:

  • To determine the incidence of thromboembolism in mild/moderate COVID-19.
  • To compare diagnostic accuracy of imaging techniques for thrombosis detection.
  • To highlight the importance of thrombotic screening in all COVID-19 cases.

Main Methods:

  • 23 patients with mild/moderate COVID-19 pneumonia underwent computed tomography pulmonary angiography (CTPA) and computed tomography venography (CTV).
  • Doppler ultrasound (DUS) was used for initial screening of extremity veins.
  • Analysis included incidence, clinical, laboratory, imaging features, and prognosis of venous thromboembolism (VTE).

Main Results:

  • A high incidence of VTE (82.6%, 19/23 patients) was detected, primarily distal limb thrombosis.
  • Doppler ultrasound (DUS) showed low sensitivity, with only one VTE patient testing positive.
  • Computed tomography venography (CTV) identified thrombosis in all affected patients, despite normal coagulation parameters (except WBC and LDH).

Conclusions:

  • Computed tomography venography (CTV) screening revealed a markedly increased incidence of thrombosis (82.6%) in mild/moderate COVID-19.
  • Screening for thrombosis is essential for all COVID-19 patients, irrespective of severity.
  • CTV demonstrates superior sensitivity over DUS for detecting thrombosis in COVID-19, warranting further research into its clinical significance.

Related Concept Videos

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
127
Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
128
Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
152
Disorders of Hemostasis01:24

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
1.6K
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
121
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.3K